RxDoctor Payments Data

Geneva Acuff

Family · Abingdon, MDNPI 1497327936

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,832 of the $9,174 with a category attached, or 85.4%. It is spread thinly across 23 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,590, more than ten times the $302 reported in 2021. Among family clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,174in general payments, 2019–2025

Across 359 payments — averaging $25.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arcutis Biotherapeutics, Inc.$1K
  • Johnson & Johnson$1K
  • Novartis$930
  • AbbVie$906
  • E.r. Squibb & Sons, L.L.C.$754
  • UCB, Inc.$688
  • plus $4K from 17 others

What the payments were for

  • Consulting fees$90010%
  • Food & beverage$7,83285%
  • Education$4425%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,174 in reported general payments places this provider in the 95th percentile of 2,843 family providers in Maryland.

See all family providers in Maryland

Medicare billing

Part B allowed, 2024
$243,768
Medicare patients
1,125
Services billed
3,966

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate208$10,015
Fluorouracil67$4,823
Ketoconazole216$3,651
Doxycycline Hyclate62$1,880
Nystatin92$1,857
GriseofulvinGriseofulvin, Microsize11$1,828
Metronidazole31$1,693
Triamcinolone Acetonide203$1,649
Gentamicin Sulfate34$1,310
ValacyclovirValacyclovir Hcl31$1,086
Imiquimod24$862
Betamethasone Dipropionate24$761
Clindamycin Phosphate29$760
Hydrocortisone96$600
Cephalexin20$485

Paid to pharmacies, not to this prescriber.

Other family in Abingdon

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →